Stock listing
TNYA Stock Price, News, Filings & Events — Tenaya Therapeutics, Inc.
Selected listing: TNYA · NASDAQ · USD · US
This page tracks Tenaya Therapeutics, Inc.'s TNYA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TNYA:NASDAQ. TNYA:NASDAQ is the stock-level entry point for investors researching Tenaya Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tenaya Therapeutics, Inc. (Ticker: TNYA) is a publicly traded company in the American market, with a market capitalization of approximately $168.17 million. The company focuses on developing innovative therapies for heart diseases. Tenaya is committed to advancing its research and product pipeline to address unmet medical needs in cardiovascular health.

- Ticker
- TNYA:NASDAQ
- Asset type
- Stock
- Market cap
- $143.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Tenaya Therapeutics, Inc. TNYA:NASDAQ stock context
This page tracks Tenaya Therapeutics, Inc.'s TNYA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TNYA:NASDAQ. TNYA:NASDAQ is the stock-level entry point for investors researching Tenaya Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Tenaya Therapeutics, Inc. (Ticker: TNYA) is a publicly traded company in the American market, with a market capitalization of approximately $168.17 million. The company focuses on developing innovative therapies for heart diseases. Tenaya is committed to advancing its research and product pipeline to address unmet medical needs in cardiovascular health.
Latest news from Tenaya Therapeutics, Inc.
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Assoc...
September 14, 2026
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
August 4, 2026
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
June 29, 2026
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in...
June 3, 2026
Research Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for TNYA:NASDAQ.
Tenaya Therapeutics, Inc. company profile
View the public company page for Tenaya Therapeutics, Inc. on 6ix.
Tenaya Therapeutics, Inc. news
Read company news and market updates connected to Tenaya Therapeutics, Inc..
Tenaya Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Tenaya Therapeutics, Inc..